Quest Diagnostics Incorporated (DGX)

NYSE · Healthcare · Diagnostics & Research
$258.28-0.31%As of 2026-11-22 · USD
Last session low $257.56Last session high $262.96
52-week low $171.1852-week high $263.19
Market cap
$28.42B
Sector
Healthcare
P/E (TTM)
25.7x
Dividend yield
1.33%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)64.4In the neutral range (30 to 70)
MACD (12, 26, 9)5.26Below its signal line (5.37); histogram -0.11
Bollinger %B (20, 2)65%Inside the bands (242.87 to 266.54)
SMA 20254.71Price is 1.4% above
SMA 50243.78Price is 5.9% above
SMA 200217.50Price is 18.7% above
ATR (20)2.22% of priceAverage true range per day
52-week position95%In the upper part of the 171.18 to 263.19 range

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

Insider filings, 90 daysNo purchases and 3 sales (about $8.2M).
Latest fiscal yearEnded 2025-12-31: revenue of $11.04B and an operating margin of 14.1%.

More in Diagnostics & Research